切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2023, Vol. 17 ›› Issue (02) : 124 -128. doi: 10.3877/cma.j.issn.1674-3946.2023.02.003

所属专题: 述评/论坛 总编推荐

专家论坛

中国微创技术在胰腺癌手术中的应用现状和展望
田锋1, 郭俊超1,()   
  1. 1. 100730 北京,中国医学科学院北京协和医院基本外科
  • 出版日期:2023-04-26
  • 通信作者: 郭俊超

Current status and prospect of minimally invasive surgery in pancreatic cancer in China

Feng Tian1, Junchao Guo1,()   

  1. 1. Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
  • Published:2023-04-26
  • Corresponding author: Junchao Guo
  • Supported by:
    The National Natural Science Foundation of China(81972324, 30600595); CAMS Innovation Fund for Medical Sciences(CIFMS)(2016-I2M-3-019); National High-tech R&D Program of China(863 Program)(2014AA020609)
引用本文:

田锋, 郭俊超. 中国微创技术在胰腺癌手术中的应用现状和展望[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 124-128.

Feng Tian, Junchao Guo. Current status and prospect of minimally invasive surgery in pancreatic cancer in China[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(02): 124-128.

手术切除是唯一可能根治胰腺癌的方法。在过去10年中,微创胰腺切除技术(包括腹腔镜和机器人技术)快速发展并取得了长足的进步,在较大型胰腺中心已成为胰腺癌手术治疗的选择之一。尽管微创胰腺切除相比开腹入路在围手术期安全性指标和术后康复中展现了部分优势,但在肿瘤学结局疗效方面仍然存在争议。现有循证医学证据以单中心、回顾性研究为主,大多混合纳入不同的病理类型。因此,微创胰腺癌根治性切除是否可带来肿瘤学疗效上的获益以及可能的获益人群均须通过高质量随机对照研究来解答。设计并执行高质量临床研究,加强多中心协作将有助于提升微创技术在胰腺癌切除中的个体化应用,提升我国在该领域的国际影响力。

Surgical resection is the only potential method to cure pancreatic cancer. In the past 10 years,minimally invasive pancreatic resection(including laparoscopy and robotics)has developed rapidly and made great progress. It has become one of the treatment options of pancreatic cancer in larger pancreatic centers. Although minimally invasive pancreatectomy has shown some advantages in perioperative variables compared with the open approach,there are still controversies on the oncological outcomes. The existing evidence of evidence-based medicine is mainly single center,retrospective research,and most of them enrolled mixed pathological types. Therefore,whether minimally invasive radical resection of pancreatic cancer can bring benefits in oncology efficacy must be answered through high-quality randomized controlled studies. The design and implementation of high-quality clinical research and the strengthening of multi-center cooperation will help to enhance the individualized application of minimally invasive technology in pancreatic cancer resection and enhance China’s international influence in this field.

[1]
Siegel RLMiller KDJemal A. Cancer statistics,2020[J]. CA Cancer J Clin202070(1):7-30.
[2]
赵玉沛,邱江东. 中国腹腔镜胰腺癌根治术:20年回顾与展望[J/CD]. 中华普外科手术学杂志(电子版)202115(03):237-240.
[3]
张太平,刘悦泽. 中国腹腔镜胰十二指肠切除术20年发展、存在问题及对策[J/CD]. 中华普外科手术学杂志(电子版)202115(03):241-244.
[4]
杨尹默,高红桥,庄岩,腹腔镜胰腺癌根治术的若干关键技术[J/CD]. 中华普外科手术学杂志(电子版)202216(04):355-359.
[5]
Gagner MPomp A. Laparoscopic pancreatic resection:Is it worthwhile?[J]J Gastrointest Surg19971(1):20-25;discussion 25-26.
[6]
Giulianotti PCCoratti AAngelini M,et al. Robotics in general surgery:personal experience in a large community hospital[J]. Arch Surg2003138(7):777-784.
[7]
Miyasaka YOhtsuka TNakamura M. Minimally invasive surgery for pancreatic cancer[J]. Surg Today202151(2):194-203
[8]
de Rooij Tvan Hilst Jvan Santvoort H,et al. Minimally Invasive Versus Open Distal Pancreatectomy(LEOPARD):A Multicenter Patient-blinded Randomized Controlled Trial[J]. Ann Surg2019269(1):2-9.
[9]
van Hilst Jde Rooij TKlompmaker S,et al. Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma(DIPLOMA):A Pan-European Propensity Score Matched Study[J]. Ann Surg2019269(1):10-17.
[10]
Raoof MItuarte PHGWoo Y,et al. Propensity score-matched comparison of oncological outcomes between laparoscopic and open distal pancreatic resection[J]. Br J Surg2018105(5):578-586.
[11]
van Hilst JKorrel Mde Rooij T,et al. Oncologic outcomes of minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma:A systematic review and meta-analysis[J]. Eur J Surg Oncol201945(5):719-727.
[12]
Feng QJiang CFeng X,et al. Robotic Versus Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma:A Systematic Review and Meta-Analysis[J]. Front Oncol202111:752236.
[13]
Chen KTong QYan JF,et al. Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma:a single-center propensity score matching study[J]. Updates Surg202072(2):387-397.
[14]
Strasberg SMDrebin JALinehan D. Radical antegrade modular pancreatosplenectomy[J]. Surgery2003133(5):521-527.
[15]
Lee SHKang CMHwang HK,et al. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria:long-term(>median 3 years)oncologic outcomes[J]. Surg Endosc201428(10):2848-2855.
[16]
Zhang HLi YLiao Q,et al. Comparison of minimal invasive versus open radical antegrade modular pancreatosplenectomy(RAMPS)for pancreatic ductal adenocarcinoma:a single center retrospective study[J]. Surg Endosc202135(7):3763-3773.
[17]
Tian FSun MQLu J,et al. Retrograde artery first approach for "shoulder" pancreatic cancers in minimally invasive distal pancreatectomy[J]. Surg Endosc202135(1):74-80.
[18]
Dai MZhang HYang Y,et al. The effect of minimally invasive or open radical antegrade modular pancreatosplenectomy on pancreatic cancer:A multicenter randomized clinical trial protocol[J]. Front Oncol202212:965508.
[19]
Wang SShi NYou L,et al. Minimally invasive surgical approach versus open procedure for pancreaticoduodenectomy:A systematic review and meta-analysis[J]. Medicine(Baltimore)201796(5):e8619.
[20]
Wang MPeng BLiu J,et al. Practice Patterns and Perioperative Outcomes of Laparoscopic Pancreaticoduodenectomy in China:A Retrospective Multicenter Analysis of 1029 Patients[J]. Ann Surg2021273(1):145-153.
[21]
Wang MLi DChen R,et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours:a multicentre,open-label,randomised controlled trial[J]. Lancet Gastroenterol Hepatol20216(6):438-447.
[22]
Poves IBurdío FMorató O,et al. Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy:The PADULAP Randomized Controlled Trial[J]. Ann Surg2018268(5):731-739.
[23]
Palanivelu CSenthilnathan PSabnis SC,et al. Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours[J]. Br J Surg2017104(11):1443-1450.
[24]
van Hilst Jde Rooij TBosscha K,et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours(LEOPARD-2):a multicentre,patient-blinded,randomised controlled phase 2/3 trial[J]. Lancet Gastroenterol Hepatol20194(3):199-207.
[25]
Pędziwiatr MMałczak PPisarska M,et al. Minimally invasive versus open pancreatoduodenectomy-systematic review and meta-analysis[J]. Langenbecks Arch Surg2017402(5):841-851.
[26]
Beal EWDalmacy DParo A,et al. Comparing Minimally Invasive and Open Pancreaticoduodenectomy for the Treatment of Pancreatic Cancer:a Win Ratio Analysis[J]. J Gastrointest Surg202226(8):1697-1704.
[27]
Zhang ZYin TQin T,et al. Comparison of laparoscopic versus open pancreaticoduodenectomy in patients with resectable pancreatic ductal adenocarcinoma:A propensity score-matching analysis of long-term survival[J]. Pancreatology202222(2):317-324.
[28]
Croome KPFarnell MBQue FG,et al. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma:oncologic advantages over open approaches?[J]Ann Surg2014260(4):633-638;discussion 638-640.
[29]
Chen KPan YZhang B,et al. Laparoscopic versus open pancreatectomy for pancreatic ductal adenocarcinoma:A systematic review and meta-analysis[J]. Int J Surg201853:243-256.
[30]
Yan QXu LBRen ZF,et al. Robotic versus open pancreaticoduodenectomy:a meta-analysis of short-term outcomes[J]. Surg Endosc202034(2):501-509.
[31]
Zureikat AHPostlewait LMLiu Y,et al. A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy[J]. Ann Surg2016264(4):640-649.
[32]
姜毓,翁原驰,金佳斌,等. 机器人辅助胰十二指肠切除术治疗胰头导管腺癌的安全性及预后分析[J]. 腹部外科201932(05):335-339.
[1] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[2] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[3] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[4] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[5] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[6] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[7] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[8] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[9] 李凯, 陈淋, 向涵, 苏怀东, 张伟. 一种U型记忆合金线在经脐单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 15-15.
[10] 李三祥, 李佳, 刘俊峰, 吕东晨, 方晖东, 谭朝晖, 刘杰, 潘佐, 乔建坤. 基于CT影像的三维重建成像技术在腹腔镜大肾上腺肿瘤切除术中的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 570-574.
[11] 赵佳晖, 王永兴, 彭涛, 李明川, 魏德超, 韩毅力, 侯铸, 姜永光, 罗勇. 后腹腔镜根治性肾切除手术时间延长和术中出血量增多的影响因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 575-580.
[12] 汪帮琦, 陈波特, 林浩坚, 许晖阳, 王镇伟, 袁雪峰, 林康健, 邱晓拂. 经腹入路3D腹腔镜联合输尿管硬镜同期处理肾盂输尿管连接部梗阻并肾盏结石的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 597-600.
[13] 刘跃刚, 薛振峰. 腹腔镜腹股沟疝日间手术在老年患者中的安全性分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 711-714.
[14] 林文斌, 郑泽源, 郑文能, 郁毅刚. 外伤性脾破裂腹腔镜脾切除术患者中转开腹风险预测模型构建[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 619-623.
[15] 牛朝, 李波, 张万福, 靳文帝, 王春晓, 李晓刚. 腹腔镜袖状胃切除联合胆囊切除治疗肥胖合并胆囊结石安全性和疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 635-639.
阅读次数
全文


摘要